Delayed Occurrence of a Severe Cutaneous Reaction in a Multiple Sclerosis Patient Taking Interferon Beta-1b

Author： Cohen Bruce A. Greenberger Paul A. Saini Sunil

ISSN： 1539-6304

Source： Allergy and Asthma Proceedings, Vol.19, Iss.2, 1998-03, pp. : 85-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon Beta in Multiple Sclerosis

By Arnason B.G.W.

Clinical Immunology, Vol. 81, Iss. 1, 1996-10 ,pp. : 1-11

Academic Press

Access to resources Recommend Favorite

In Vitro Assessment of the Biologic Activity of Interferon Beta Formulations used for the Treatment of Relapsing Multiple Sclerosis

Journal of Immunoassay and Immunochemistry, Vol. 35, Iss. 3, 2014-07 ,pp. : 288-299

Taylor & Francis Ltd

Access to resources Recommend Favorite

Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells - An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta

By Bergh F.T. Dayyani F. Ziegler-Heitbrock L.

Journal of Neuroimmunology, Vol. 146, Iss. 1, 2004-01 ,pp. : 176-188

Elsevier

Access to resources Recommend Favorite

Choroiditis in a Patient with Multiple Sclerosis

By Correnti Anthony Huang John

Ocular Immunology and Inflammation, Vol. 16, Iss. 5-6, 2008-09 ,pp. : 233-235

Informa Healthcare

Access to resources Recommend Favorite

B-Cell Lymphoma in a Patient with Complete Interferon Gamma Receptor 1 Deficiency

By Bax Hannelore Freeman Alexandra Anderson Victoria Vesterhus Per Laerum Dan Pittaluga Stefania Wilson Wyndham Holland Steven

Journal of Clinical Immunology, Vol. 33, Iss. 6, 2013-08 ,pp. : 1062-1066

Springer Publishing Company

Access to resources Recommend Favorite